Evidence map›Paper›PMID 25393897›Full record

ArticleViruses2014

CMV-promoter driven codon-optimized expression alters the assembly type and morphology of a reconstituted HERV-K(HML-2).

Oliver Hohn, Kirsten Hanke, Veronika Lausch, Anja Zimmermann, Saeed Mostafa, Norbert Bannert

Abstract read
In one paragraph

Article in Viruses, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Oliver HohnHIV and Other Retroviruses, Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany. HohnO@rki.de.
Kirsten HankeHIV and Other Retroviruses, Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany. HankeK@rki.de.
Veronika LauschHIV and Other Retroviruses, Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany. LauschV@rki.de.
Anja ZimmermannHIV and Other Retroviruses, Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany. ZimmermannA@rki.de.
Saeed MostafaHIV and Other Retroviruses, Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany. MostafaS@rki.de.
Norbert BannertHIV and Other Retroviruses, Robert Koch Institute, Nordufer 20, 13353 Berlin, Germany. BannertN@rki.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The HERV-K(HML-2) family contains the most recently integrated and best preserved endogenized proviral sequences in the human genome. All known elements have nevertheless been subjected to mutations or deletions that render expressed particles non-infectious. Moreover, these post-insertional mutations hamper the analysis of the general biological properties of this ancient virus family. The expression of consensus sequences and sequences of elements with reverted post-insertional mutations has therefore been very instrumental in overcoming this limitation. We investigated the particle morphology of a recently reconstituted HERV-K113 element termed oriHERV-K113 using thin-section electron microscopy (EM) and could demonstrate that strong overexpression by substitution of the 5'LTR for a CMV promoter and partial codon optimization altered the virus assembly type and morphology. This included a conversion from the regular C-type to an A-type morphology with a mass of cytoplasmic immature cores tethered to the cell membrane and the membranes of vesicles. Overexpression permitted the release and maturation of virions but reduced the envelope content. A weaker boost of virus expression by Staufen-1 was not sufficient to induce these morphological alterations.

Indexed as

Gene Expression Regulation, ViralPromoter Regions, GeneticVirus AssemblyCell LineCytomegalovirusEndogenous RetrovirusesHumansMicroscopy, Electron, TransmissionVirion

Identifiers

PMID25393897
PMCPMC4246225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.